Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-618-7 | CAS number: 4430-18-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Acid Violet 43 was tested in two different Amestests according to OECD guideline 471,both in strains TA 1535, TA 1537, TA 98 and TA 100 with and without metabolic activation.Materials of different purity (54.4% resp.95%) were used in these studies.In both experiments,the test substances did not increase the number of revertants in any strain in the presence or absence of S9.
In a mouse lymphoma assay according to OECD guideline 476,the test substance did not induce gene mutations in two independent experiments in cell line L5178Y at the tk+/--locus with and without metabolic activation.In experiment 1 strong cytotoxicity was observed at the highest dose level tested after 4-hour treatment (±S9), and in experiment 2 relevant toxic effects were observed at the highest concentration tested under precipitation after 24-hour treatment (-S9).
Acid Violet 43 was tested in two different experiments in an in vitro chromosome aberration test in human lymphocytes according to OECD guideline 473.The highest concentration selected for each of these tests was the lowest concentration achieving a reduction of the mitotic index in the range 50-75%.For the 24-h harvest time the test substance did not induce any significant increase in the aberrant cells frequency, with and without metabolic activation in both experiments. For the 48-h harvest time performed during the repeat test,a significant increase in the aberrant cells frequency was recorded in the 2-h treatment group at the highest concentration with metabolic activation as well as in the 48-h treatment group at the highest concentration without metabolic activation. Aberrations consisted almost of chromatid deletions,and the proportion of cells bearing numerical aberrations was also slightly increased. These changes were observed together with a reduction in mitotic index to 46 and 52 % of controls.
According to the results of this study Acid Violet 43has the potential to induce chromosome aberrations in cultured mammalian cells.
In another chromosome aberration study according to OECD guideline 473,Acid Violet 43 was tested in two independent tests in Chinese Hamster Ovary Cells.The highest concentration for each experimental condition was selected on the basis of solubility or cytotoxicity criteria.In both experiments treatment of cultures with the test substance in the presence and absence of S9 and at both harvest times,resulted
in statistically significantly increased numbers of cells bearing structural aberrations, chromatid and/or chromosome deletions and exchanges. Some of these increases were observed in the absence of overt cytotoxicity.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (positive)
Genetic toxicity in vivo
Description of key information
Acid Violet 43 was tested in an in vivo micronucleus study according to OECD guideline 474 on Swiss mice which received a single oral dose of 2000 mg/kg.In all groups treated with the test substance, the mean values of micronucleated polychromatic erythrocytes were similar to those of their respective vehicle group at each sampling time and no statistically significant differences were observed. At the 48-h sampling time, the PCE/NCE ratio was lower than in controls but this difference was mainly due to a high control value and does not clearly indicate bone marrow toxicity of the test substance.
To rule out any clastogenic potential of Acid Violet 43, the in vivo clastogenic potential was evaluated in an additional oral bone marrow micronucleus test in mice using conditions selected to maximize exposure of the animals.Acid Violet 43 was given to mice by gavage at the test limit dose level of 2000 mg active dye. There were no increases in the incidence of micronucleated polychromatic erythrocytes.There was no evidence of bone marrow toxicity but toxicokinetic evaluation confirmed systemic exposure of the animals and thus target organ exposure,since it is generally recognized that detection of test-related material in blood or plasma is adequate for validating bone marrow exposure .Accordingly, this additional in vivo bone marrow micronucleus test confirmed that Acid Violet 43 has no clastogenic potential in vivo.
Acid Violet 43 was also tested in an UDS-test according to OECD guideline 482 on
Wistar rats at dose levels of 82 and 816 mg active dye.Dose levels were selected on the basis of a sighting test in which 816 mg active active dye/kg was the Maximal Tolerated Dose, associated with piloerection and blue-coloured urine.For each animal, hepatocytes were isolated from the liver and at least three primary cultures were established. Autoradiographic slides from 2 cultures/animal were prepared and the unscheduled synthesis of DNA was evaluated by the incorporation of tritiated methyl thymidine in 50 cells/slide.
No changes from controls in the number of nuclear and net grain counts were observed in Acid Violet 43 treated rats at both dose levels and both killing times of 2h and 16h respectively.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.